Updated Guide now available
In collaboration with colleagues from NHS Scotland, academia and individuals with lived experience, Scottish Government has developed an updated “Type 2 Diabetes Mellitus – Quality Prescribing Strategy: Improvement Guide 2024 to 2027”. This resource focuses on delivery of safe person centred care through promoting safe prescribing and practical review of medications to ensure their effective use in clinical practice. This guide also aims to promote shared decision making using the 7 step medicine review model in order for patients to be involved in all steps of their treatment.
The guide can be accessed on the main Scottish Government website here.
An accompanying clinician toolkit for implementation is available here.
90 Second summary video here.
email address for feedback: EPandT@gov.scot.
Quality Prescribing for Diabetes 2018 – 2021 – Now replaced with 2024-2027 version
The Quality Prescribing for Diabetes 2018 – 2021 was written by the Scottish Government, in partnership with NHS Scotland.
The strategy aims to promote high quality prescribing of medicines to treat type 2 diabetes and, equally importantly, nonpharmaceutical approaches to management. The document is demographic variation, in some Boards, prevalence is as high as 5.5%.
This advice is based on existing clinical guidance, in particular SIGN 116 and 154, which reviewed the clinical evidence for medication for people with diabetes in 2017, and should be considered a companion document.
The full document can be viewed here.